Aceragen | IDRA - Marktkapitalisierung



Marktkapitalisierung Veränderung Datum
Abbott USD 217.86B 15.25B 2025-12
Agenus USD 107M 16M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Alterity Therapeutics Limited AUD 30M 26M 2026-04
Amgen USD 176.25B 24.32B 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Cipla INR 1.22T 6.47B 2025-12
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 144.67M 7.17M 2025-12
CSL USD 55.89B 20.42B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Merck USD 261.26B 51.62B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Pfizer USD 141.57B 6.48B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
X T L Biopharmaceuticals USD 22M 8M 2024-12